TradingMarkets’ 7 Stocks You Need To Know About Today
Pfizer
(
PFE |
Quote |
Chart |
News |
PowerRating) is pulling all Celebrex ads. Last week it was
reported the drug increased risk of heart attack in higher doses.
Nokia is setting an upbeat tone, expecting 10% growth in 2005.
Pharmos
(
PARS |
Quote |
Chart |
News |
PowerRating) said its dexanibrinol was not effective.
Ryder guided lower for 2005.
Audible Systems
(
ADBL |
Quote |
Chart |
News |
PowerRating) was the subject of downbeat comments in
Barron’s.
Standard Microsystems
(
SMSC |
Quote |
Chart |
News |
PowerRating) reported 0.03 vs an 0.11 estimate.
JP Morgan raised guidance on Intel by a penny.